Munagala Kamesh, Tibshirani Robert, Brown Patrick O
Department of Biochemistry, Stanford University School of Medicine, 466 Gates Computer Science, Stanford, CA 94305, USA.
BMC Bioinformatics. 2004 Mar 3;5:21. doi: 10.1186/1471-2105-5-21.
A central challenge in the molecular diagnosis and treatment of cancer is to define a set of molecular features that, taken together, distinguish a given cancer, or type of cancer, from all normal cells and tissues.
Discriminative margin clustering is a new technique for analyzing high dimensional quantitative datasets, specially applicable to gene expression data from microarray experiments related to cancer. The goal of the analysis is find highly specialized sub-types of a tumor type which are similar in having a small combination of genes which together provide a unique molecular portrait for distinguishing the sub-type from any normal cell or tissue. Detection of the products of these genes can then, in principle, provide a basis for detection and diagnosis of a cancer, and a therapy directed specifically at the distinguishing constellation of molecular features can, in principle, provide a way to eliminate the cancer cells, while minimizing toxicity to any normal cell.
The new methodology yields highly specialized tumor subtypes which are similar in terms of potential diagnostic markers.
癌症分子诊断与治疗中的一个核心挑战是确定一组分子特征,这些特征综合起来能将特定的癌症或癌症类型与所有正常细胞和组织区分开来。
判别边界聚类是一种用于分析高维定量数据集的新技术,特别适用于来自与癌症相关的微阵列实验的基因表达数据。分析的目标是找到肿瘤类型的高度特化亚型,这些亚型具有相似性,即拥有一小部分共同提供独特分子特征的基因组合,从而将该亚型与任何正常细胞或组织区分开来。原则上,检测这些基因的产物可为癌症的检测和诊断提供依据,并且针对这些独特分子特征组合的特异性治疗原则上可为消除癌细胞提供一种方法,同时将对任何正常细胞的毒性降至最低。
新方法产生了在潜在诊断标志物方面相似的高度特化肿瘤亚型。